🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07299318
Starting soon Observational

Multimodal Deep Learning for Lymph Node Metastasis in Thyroid Cancer

NCT07299318 · tracked via the Priya Life Science China tracker
Sponsor
West China Hospital
Phase
Observational
Started
2026-01-01
Last updated
2025-12-23

Condition(s) studied

Papillary Thyroid Carcinoma

Investigational drug(s) / intervention(s)

not intervention

not intervention: This is a retrospective observational study in which participants will not undergo any interventions, and only data collection and analysis will be performed on the participants.

Study summary

Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy in clinical practice, accounting for approximately 85% of all thyroid malignancies. The occurrence of cervical lymph node metastasis further increases the risk of local tumor recurrence and distant metastasis, thereby reducing patient survival rates. Pathological examinations reveal that approximately 30-80% of PTC patients have lymph node metastasis. Early detection of metastatic lymph nodes and the development of individualized treatment plans are crucial for improving patient prognosis. Currently, the primary method for diagnosing lymph node metastasis is ultrasound-guided fine-needle aspiration, but its accuracy is limited by sample quality and carries a risk of false-negative results. In recent years, deep learning technology has demonstrated significant potential in the field of medical image analysis. Therefore, the investigators aim to develop a deep learning model based on neck ultrasound to more accurately predict lymph node metastasis.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: Cases aged 18-80 years who underwent thyroid ultrasound examination and postoperative pathological examination of the thyroid. Cases with a first-time diagnosis of papillary thyroid carcinoma. Cases who underwent lymph node dissection Exclusion Criteria: Cases aged \<18 years or \>80 years. Cases with poor-quality ultrasound images. Cases with incompletely visualized nodules. Cases with images showing multiple distinct lesions. Cases belonging to special populations. Cases with concurrent other tumors. Cases with a history of thyroid cancer resection

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
West China hospital of Sichuan University Chengdu Sichuan

More West China Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07299318 on ClinicalTrials.gov ↗ ← All trials in China